# Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors

> **NCT01778686** · NA · COMPLETED · sponsor: **Gitte Moos Knudsen** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Citalopram and Pindolol
- **OTHER:** Placebo
- **DIETARY_SUPPLEMENT:** Acute tryptophan depletion

## Key facts

- **NCT ID:** NCT01778686
- **Lead sponsor:** Gitte Moos Knudsen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01778686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01778686, "Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01778686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*